Interphex 2011
in-Pharmatechnologist.com presents a round up of all the latest developments in pharmaceutical manufacturing, processing and production technologies that were unveiled at Interphex 2011.
EMD Millipore talks single use technology at Interphex 2011
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
PTI and Nikka Densok team on lab-scale HVLD
PTI Inspection Systems and Nikka Densok USA have teamed up to take high-voltage leak detection (HVLD) from the factory floor to the pharmaceutical lab.
LB Bohle sees increasing demand for ‘try before you buy’ demos
LB Bohle says healthy level of demand for processing technology demos at its recently opened service centre is an indication of processing tech market recovery.
Patheon talks about backup manufacturing service at Interphex 2011
Contract manufacturing organisation (CMO) Patheon has launched a new ‘back up’ sterile manufacturing service to help drug firms cope with supply interruptions and, it hopes, attract new business.
PAT and QbD changing powder flow analysis says Freeman
Regulatory demands for ‘in process’ performance data have changed the pharma sector’s approach to materials analysis and enhanced the quality of the drugs it produces according to Freeman Technology.
Pharma future bright for Puerto Rico says PRIDCO
The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial Development Company (PRIDCO).
ATMI unveils helium integrity testing for bioprocess vessels at Interphex 2011
ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level.
China’s booming pharma sector welcomes western investors
Double-digit growth in the Chinese pharmaceutical sector will increasingly make the nation a lucrative place for Western companies to do business, delegates heard at the InterPhex trade event in New York.
China's new approvals system brings outsourcing opportunity
A new, tougher approvals policy for pharmaceutical products in China will bring opportunities for Western contract companies able to help domestic firms meet the strict new rules, according to a seminar at InterPhex in New York.
Planning key to cell therapies' $6bn growth
Planning the commercial production and delivery of effective cell therapies will be key if the sector is to achieve forecast growth of $6bn within nine years, according to a seminar at the InterPhex trade event in New York City.
US FDA opens Interphex 2011 with presentation backing continuous manufacturing
The US FDA set out its support for properly planned continuous manufacturing during a fascinating opening presentation at the first day of Interphex 2011 in New York, US yesterday.
Spotlight
  ICH sends Q11 guidelines to EU, US & Japanese regulatorsThe ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union... |
  in-Pharmatechnologist.com's review of Interphex 2012in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak... |
 Effective controls still lacking for continuous processing says Interphex panelContinuous processing is still hamstrung by a lack of control systems and is not ready for specific... |
 BASF buys omega-3 maker Equateq citing pharma potentialBASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key... |
 EMA outlines manufacturing quality docs for biologics trialsThe EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials. |